Antioxidant trial aims to tame Kids' gut inflammation, cut steroid need
NCT ID NCT05539625
Summary
This study aimed to see if adding a daily MitoQ antioxidant capsule to standard treatment could better control ulcerative colitis in children and teens. It planned to test if MitoQ improved symptoms, reduced gut inflammation, and helped patients avoid stronger medications like steroids. The trial was designed as a feasibility study to see if a larger, definitive trial could be run, but it was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
NHS Lothian
Edinburgh, United Kingdom
Conditions
Explore the condition pages connected to this study.